Levi & Korsinsky has started an investigation into Orthofix Medical Inc. over potential breaches of fiduciary duties. This legal scrutiny could impact current shareholders as the firm explores claims of financial misconduct. Shareholders can request more information or contact the law firm for assistance. The investigation highlights concerns about corporate governance at Orthofix and may lead to legal action or shareholder compensation.
Orthofix Medical Inc. is under investigation for possible breaches of fiduciary duties. For readers following the health sector, here is Pluang's market snapshot as of Oct 22, 2026 03:02 WIB: out of 150 priced US health stocks, 73 rose and 75 fell. Notable movers include Illumina, Inc. (ILMN) up 5.89% at USD 283.70 with a typical hold time of 83 days and a buy order activity of 68%, Bruker Corporation (BRKR) up 5.85% at USD 59.20 with a 13-day hold time, and Heron Therapeutics Inc. (HRTX) down 5.84% at USD 0.33 with an 80% buy order activity and a 37-day hold time.
National Healthcare Properties (NHP) announced that Lindsay Gordon, its Executive Vice President and Head of Senior Housing, has been elected to the executive board of the American Senior Housing Association (ASHA). ASHA is a leading national organiz...
Akzo Nobel reported Q3 2026 earnings with revenue of $2.85 billion and EPS of $0.38, both below analyst estimates of $2.96 billion and $0.42 respectively. Despite these misses, the company's core profit exceeded expectations, indicating underlying st...
United Airlines reported a strong third-quarter revenue of $17.9 billion, up 17.4% year-over-year, and provided optimistic guidance for the fourth quarter. Jefferies raised its price target for United Airlines stock to $142 from $134, suggesting a 36...
OFG Bancorp reported third-quarter earnings per share of $1.33, surpassing analyst estimates of around $1.23. However, its revenue came in slightly below expectations at $185.7 million versus estimates near $187 million. The earnings beat was driven ...
SEI Investments is set to report its Q3 2026 earnings on October 21 after market close, with analysts projecting earnings per share of $1.59 and revenue of $658.54 million. These estimates indicate a strong year-over-year growth of 22.3% in earnings ...
